The biomedical sector is undergoing a paradigm shift as researchers move away from traditional two dimensional cell cultures toward more sophisticated three dimensional models. This transition is the primary catalyst for the current organoids market forecast, which envisions a future where human biology is replicated with pinpoint accuracy in a laboratory setting. Organoids, which are...